适应性免疫机制联合介导新冠疫苗接种后心肌损伤
该研究对mRNA疫苗接种后发生急性心肌心包炎(AMP)的患者、重症新冠住院患者及无心脏副作用的健康人进行外周血T细胞深度表型分析,并用小鼠心脏炎症模型验证。发现AMP患者T细胞识别疫苗编码的Spike表位与心脏自身蛋白同源,其中模拟心肌细胞K+通道的表位可在小鼠诱导AMP,且T细胞自身免疫局限于表达cMet的心脏趋向性T细胞,cMet抑制可预防。结论提示分子模拟、TCR亲和力及归巢印记共同介导AMP。
要点
- mRNA疫苗后AMP患者T细胞可识别与心脏自身蛋白同源的Spike表位。
- 模拟心肌K+通道的Spike表位可在小鼠诱导急性心肌心包炎。
- cMet表达的心脏趋向性T细胞介导自身免疫,cMet抑制可预防。
核心结论
- mRNA疫苗接种后AMP由分子模拟、T细胞受体亲和力及心脏归巢印记等 distinct 免疫成分共同介导。
研究设计与样本
- 对mRNA疫苗接种后发生AMP患者、重症新冠住院患者及无心脏副作用的健康受试者进行外周血T细胞深度表型分析。
- 采用共享表位诱导患者和小鼠功能性反应并引发AMP的实验性心脏炎症模型进行验证。
主要发现
- AMP患者T细胞识别疫苗编码的Spike表位与心脏自身蛋白同源。
- 模拟心肌细胞表达K+通道氨基酸序列的表位可在小鼠诱导AMP。
- mRNA疫苗后AMP患者对Kv2的功能反应呈现与AMP小鼠及自身免疫性心肌炎相似的细胞因子产生扩展模式,而新冠患者未显示。
- T细胞自身免疫局限于表达cMet的心脏趋向性T细胞,cMet抑制可预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 pandemic, caused by SARS-CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they induce protective antiviral immunity. Acute myopericarditis (AMP) development after vaccination has repeatedly been reported; however, the pathogenesis of this complication remains elusive. METHODS: In-depth phenotyping of peripheral blood T cells was undertaken in cohorts of patients who developed AMP after mRNA vaccination, patients hospitalized for severe COVID-19, and healthy subjects with no cardiac side effects after mRNA vaccine. Validation studies were carried out using an experimental model of cardiac inflammation, in which a shared epitope elicits functional responses in patients and mice and induces AMP. RESULTS: We show that T cells from patients with AMP recognize vaccine-encoded Spike epitopes homologous to those of cardiac self-proteins. One of these epitopes, mimicking an amino acid sequence from a cardiomyocyte-expressed K+ channel, induced AMP in mice. When functional responses to the Kv2 were analyzed, patients with AMP after mRNA vaccination, but not patients with COVID-19, displayed an expanded pattern of cytokine production similar to that observed in AMP mice and in autoimmune myocarditis. Crucially, T-cell autoimmunity segregates to cardiotropic cMet (c-mesenchymal epithelial transition factor)-expressing T cells and is prevented by cMet inhibition, suggesting that heart homing imprinting, permitted by the unique mRNA vaccine biodistribution, is required for AMP development. CONCLUSIONS: AMP development after mRNA vaccines is mediated by distinct immune components, including molecular mimicry, T-cell receptor affinity, and, importantly, homing imprinting.
引用
- Fanti S, Dyer C, Ingimarsdóttir IJ, et al. Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination. Circulation. 2025. PMID: 41164857. doi:10.1161/CIRCULATIONAHA.125.074644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。